The Pharmaceutical Research and Manufacturers of America (PhRMA) today released new advertising as part of its “From Hope to Cures” campaign, highlighting the stories of rare blood and lung cancer survivors.
The newest video in the collection features Matt, who was diagnosed nearly seven years ago with advanced non-small cell lung cancer. When he was diagnosed, he was given a slim chance of living up to five years. However, today Matt continues to lead an active life due to recent advancements in targeted gene therapies and innovations in cancer medicines.
The latest print and digital ads feature Jamie, a vibrant woman diagnosed 15 years ago with chronic myelogenous leukemia (CML). Watching her son grow up was a primary focus for her, and she’s been able to continue to do that and so much more. Thanks to advancements in CML treatments, today she maintains her sense of humor and imparts an infectious joy on those who meet her.
Earlier this year, the first collection of digital and print ads was released featuring Rhys, a five-year-old living with type 1 diabetes and celiac disease. Unveiled alongside the advertising was a video, titled “We’re Fighting Back,” which features both Rhys and Jamie, as well as Jen, a researcher who wakes up every day working to find new treatments and cures for patients.
To view the multimedia release go to:
http://www.multivu.com/players/English/7738431-phrma-from-hope-to-cures/
Cigna (NYSE: CI) today unveiled its new TV Doctors of America campaign to encourage people to improve their health by going for their annual check-up, knowing their biometric numbers for blood pressure, cholesterol, blood sugar and body mass index (BMI), and taking control of their health. Supporting Cigna’s effort are actors Patrick Dempsey, Donald Faison, Neil Patrick Harris and Kate Walsh. All four actors starred as doctors on TV and are striking doctor poses, donning scrubs and using their celebrity influence to shine a spotlight on preventive care and the importance of going to a real doctor for an annual check-up that can help save lives.
To view the multimedia release go to:
https://www.multivu.com/players/English/8163851-cigna-americas-tv-doctors-go-know-take-control/
As sleaze oozes from the Pentagon,
banished Marine and Naval Academy alum Susanna Marcasi finds a web of
corruption and must take on a man to whom all are beholden, Defense
Secretary Manfred Stahl. Can she bring down the cloistered power
brokers deep within the military’s superstructure and survive? Blood
Stripe: The Susanna Marcasi Chronicles. Find out more at:
http://www.GinaMariaDiNicolo.com or on Amazon at:
http://j.mp/Blood-Stripe Cincinnati City Beat and
Amazon reviewer John Kelly says “Like a literary version of ‘A Few Good
Men (and Women)’ on steroids, Gina Maria DiNicolo rips into your
emotional core like a ‘kill shot’ from page one and never lets up for
322 pages. This book, not for the weak of heart, tells the story of
strength, courage and no mercy in the most elite units of the U.S.
Armed Forces.” Baltimore native Gina Maria DiNicolo graduated
from the U.S. Naval Academy with a degree in history and an attraction
to the unconventional. She accepted a commission in the U.S. Marine
Corps where she worked in aviation, recruiting, history, and public
affairs. As a fulltime author and historian, in addition to her two
books, DiNicolo has written scores of articles for the Military Officer
Magazine and other publications. After publishing Blood Stripe, she
sought to get her historian game on and accepted a one-year, work/study
assignment as a senior editor for the U.S. Army Center of Military
History in Washington, D.C., producing studies on military operations
in Iraq and Afghanistan. She is a dancer specializing in Argentine
Tango. For a review copy of Blood Stripe: The Susanna
Marcasi Chronicles or to arrange an interview with Gina Maria
DiNicolo contact Scott Lorenz of Westwind Communications Book
Marketing http://www.book-marketing-expert.com/ or by phone
734-667-2090.
Lustgarten Foundation funded researchers at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins have designed a multi-analyte blood test that can detect the presence of pancreatic cancer as part of a panel of eight common cancers (pancreas, ovary, liver, stomach, esophagus, colorectum, lung and breast) as reported in the online edition of Science today. The test utilizes combined assays for genetic alterations and protein biomarkers and has the capacity not only to identify the presence of relatively early cancer, but also to localize the organ of origin of these cancers.
“The potential this has for pancreatic cancer is unprecedented,” says Anne Marie Lennon, M.D., Ph.D., Associate Professor of Medicine, Director, Pancreatic Cyst Center of the Ludwig Center at the Johns Hopkins Kimmel Cancer Center. “We know that in 80-85 percent of pancreatic cancer cases, it’s detected too late, leaving the patient with few options. Developing a blood screening test for pancreatic cancer has been an urgent goal, because catching the disease early will be the way we get to long-term survival.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8213751-lustgarten-foundation-pancreatic-cancer-blood-test/
Team In Training. Light The Night. Man & Woman of the Year. Student Series. Leukemia Cup Regatta. More than 13 million participants in these popular fundraising campaigns last year alone helped The Leukemia & Lymphoma Society (LLS) invest more than $1 billion in research to advance lifesaving treatments and cures for blood cancer patients.
For Blood Cancer Awareness Month this September, LLS is reminding us that despite progress, much work still needs to be done to save more lives. More than 1.2 million people in the U.S. are living with or in remission from a blood cancer. Leukemia causes more deaths than any other cancer among children, adolescents and adults younger than 20 years. Leukemia, lymphoma and myeloma are expected to cause the deaths of an estimated 58,320 people in the U.S. in 2016.
To view the multimedia release go to:
http://www.multivu.com/players/English/7554853-lls-blood-cancer-awareness-month/
Going on the offensive against one of the most daunting challenges in cancer, The Leukemia & Lymphoma Society (LLS) today announced the launch of a groundbreaking, collaborative clinical trial for acute myeloid leukemia (AML), a deadly disease which has seen few improvements in treatments in more than 40 years.
Beat AML was announced yesterday by Vice President Biden, along with many new, Moonshot inspired initiatives across industry, non-profit and government.
AML is the most lethal of the blood cancers, which together are the third leading cause of cancer deaths in the U.S.; AML is responsible for more than 10,000 deaths each year. Despite advances in treating other blood cancers, the standard of treatment for AML – a combination of toxic chemotherapies – has remained the same for more than 40 years. Overall prognosis remains poor, with a five-year survival rate below 20 percent for patients over age 60.
To view the multimedia release go to:
http://www.multivu.com/players/English/7554854-lls-beat-aml-acute-myeloid-leukemia/
Every three minutes someone in the U.S. is diagnosed with a blood cancer. No one knows this better than “Nashville” star Charles Esten and his wife Patty. Esten’s 15-year-old daughter, Addie, was diagnosed with leukemia at age 2 ½. Naturally, their world was turned upside down. But, they quickly learned that there was hope, based on research to advance new treatments and cures for leukemia, much of it funded by The Leukemia & Lymphoma Society (LLS).
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7491051-charles-esten-light-the-night-walks/
Today, VSP Vision Care, the largest not-for-profit vision benefits provider in the United States, and market research agency YouGov released new findings showing that half of people in the U.S. are neglecting their eyes despite 84 percent of people rating vision as their most important sense. This disconnect occurs because people don’t understand the importance of annual eye exams and its connection to overall health.
In fact, only 1 percent of people know that signs of serious conditions like thyroid disease, high blood pressure, autoimmune disorders and certain types of cancer can be detected through annual eye exams. This is concerning because even if you have naturally good vision and don’t need prescription glasses, you still need an annual eye exam to protect your overall health.
To view the multimedia release go to:
https://www.multivu.com/players/English/8363551-vsp-vision-care/
Today, Novo Nordisk announced new phase 3 interim data from its guardianTM2 trial for its recombinant coagulation factor VIII (rFVIII) product NovoEight® (turoctocog alfa), the first new rFVIII molecule in over a decade, which shows that it provides long-term reduction from bleeding in people with haemophilia A when used as a preventative treatment.1 The results were presented at the World Federation of Haemophilia (WFH) World Congress and support findings from other studies within the guardianTM clinical programme that found NovoEight® demonstrated good efficacy in preventing and treating bleeds without inhibitor development in previously treated patients.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/71400529-novoeight-reduction-of-bleeding-haemophilia-a
https://www.anger.land/
Greetings Citizens Angerland's debut dose of heavy post-punk rage-n-roll has arrived! Introducing; 'The Clown King'.
"It’s great to finally get these songs out – they reflect the angry times we will live in. A soundtrack to a rage without borders.
In the words of President Trump; "It's idealistic, it's wonderful, it's a beautiful thing."
Streaming and download to follow via all major outlets.
Released as part of 'The Clown King' EP also featuring 'This Blood Machine' and 'A Comedy Of Hate'
Directed by Gary J Brady @ Total Thrive Productions
Clown make-up by Luke Renouf
BITCOIN CHAINCOIN Song Pump & Hodl Animated Video by Master CryptoSkrilla
Coming Soon Crypto Info News you can use to help you step your game up. Send Bitcoin Donations: 12iWmM1VbQjuBSMvwadsCuxKKyS1VPtV9
Send Ethereum Donations
da3bf4b560e198bbfe8a7b3f85de25250e59f62434ca0bf322a07e4df46bf220
https://bitconnect.co/?ref=masterhenry
If you already Own Bitcoin, or would like to learn how to own crypto currency and make daily interest on it, no joke, Then read on.
- Earn daily interest of an average of .9% (30 day average) How much does your savings make daily? - Be your own bank! - It only takes $100 to get started. - More opportunities to use your crypto to make more return. - Full trading platform - Referral bonus program - Plus more... - Free to join website, loaded with Bitcoin information if you'd like to know more. - I'll even give you CASH back to do it. That's right, 3% on your first investment, and you start earning interest right away. - Just use the link below. Sign up. Check it out. You will be surprised.
https://bitconnect.co/?ref=masterhenry
I think this is one of the best opportunities, ground floor with the currency revolution. Any questions, please email: cryptoskrilla@gmail.com
Yobit: Buy & Trade Cryptos
https://yobit.io/?bonus=jVkFuyxZ
Cryptopia: Buy & Trade Cryptos
https://www.cryptopia.co.nz/Register?referrer=henrymaster
PAXFUL: Buy Bitcoin
https://paxful.com/roots/buy-bitcoin?affiliate=W24QWenqYKa
Id: W24QWenqYKa
Check out Crypto Blood He Solid as a rock https://youtu.be/gEFJMylC1RU
